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The SIADH was first described in patients with bron-
chogenic carcinoma by Schwartz and colleagues19 in
1957. Since that time, it has been reported in association
with many surgical procedures, anesthetic agents, brain
injury, spinal surgery, and tumors.3,5,6,15,17,18,24 In these pa-
tients, loss of sodium and water retention have been at-
tributed to sustained endogenous production and release
of ADH or ADH-like substances without any physiologi-
cal or pharmacological stimuli to ADH release. The
SIADH is defined as retention of water, loss of sodium,
and inappropriately concentrated urine in normovolemic
or hypervolemic patients in whom renal and adrenal func-
tion is normal. 
Physiological and abnormal secretion of ADH during
the perioperative period has been described by many dif-
ferent authors.2,4,16,23 In this paper, we will discuss hypona-
tremia and SIADH together as a complication of spinal
surgery. We will review the literature and discuss the diag-
nosis, pathophysiology, and management of SIADH after
spinal surgery.
HYPONATREMIA AND SIADH
Hyponatremia is a very common disturbance of fluid
and electrolyte balance in the critically ill patient. Hypo-
natremia is defined as a sodium value of 135 mEq/L or
less. Total body sodium may be increased or decreased in
the presence of excess extracellular free water. In deple-
tional, or hypertonic hyponatremia, the total body concen-
tration of sodium is decreased in the presence of decreased
or normal extracellular fluid. In dilutional, or hypotonic,
hyponatremia, the total body concentration of sodium is
either normal or increased in the presence of increased
total body water. In the latter case SIADH is defined and
is characterized by hypotonic hyponatremia and impaired
urinary dilution in the absence of any known nonosmotic
stimulus to ADH secretion, such as hypovolemia, hypo-
tension, or adrenal insufficiency.9,10 In 1957, Schwartz and
colleagues19 described the clinical parameters required for
a diagnosis of SIADH (Table 1).
The SIADH is seen in patients with a variety of medical
conditions, including carcinoma of the bronchus, prostate,
and ovary; agenesis of the corpus callosum and cleft lip
and palate; closed or penetrating head trauma; infectious
processes such as an abscess or tuberculosis of the lung or
brain, encephalitis, or bacterial or viral meningitis; asth-
ma; reliance on positive-pressure ventilation; and neuro-
logical conditions such as Guillain–Barré syndrome, mul-
tiple sclerosis, hydrocephalus, cerebrovascular occlusion
or hemorrhage, and cavernous sinus thrombosis.8–11 The
SIADH has also been reported as a postoperative compli-
cation of cardiothoracic, brain, or spine surgery. In most of
these conditions, SIADH is caused by either ectopic pro-
duction or osmotically inappropriate secretion of ADH by
the neurohypophysis. Postoperative SIADH has been at-
tributed to stress16 and, in cases of neurological or spinal
surgery, to invasion of the dura mater and traction on the
neural pathways.12 Callewart, et al.,5 have reported the
development of SIADH in patients who had undergone
revision surgery or had experienced a blood volume loss
greater than 10%. On the other hand, Lieh-Lai, et al.,12
found no relationship between blood loss or type of spinal
surgery and the development of SIADH. 
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Abbreviations used in this paper: ADH = antidiuretic hormone;
cAMP = adenosine 3✁,5✁-cyclic monophosphate; CNS = central
nervous system; CPEM = central pontine and extrapontine myeli-
nolysis; CVP = central venous pressure; SIADH = syndrome of in-
appropriate secretion of ADH.
Pathophysiology of SIADH
Antidiuretic hormone, a product of the hypothalamus, is
stored in the posterior pituitary gland and controls the
metabolism of water. It is synthesized as a prohormone in
the supraoptic and paraventricular nuclei and is cleaved
into its active form during transportation to the posterior
pituitary. Under normal conditions, ADH is secreted in
response to a decreased intravascular volume and serum
hyperosmolality. This hormone acts on cells of the dis-
tal renal tubules and the collecting duct via the cAMP
pathway. An increased level of cAMP increases the per-
meability of cells to free water, inducing free water ab-
sorption.13 Antidiuretic hormone is also a potent vasocon-
strictor at levels between 2.5 and 20 pg/mL, which is
above the physiological range. In patients with SIADH,
excess water is retained in the extracellular and intracellu-
lar compartments, decreasing the concentration of sodium
and other solutes such as uric acid and plasma urea. In ad-
dition, the expansion of plasma and extracellular volume
decreases the level of aldosterone and of renin activity,
and increases the urinary excretion of sodium as an appro-
priate response. The combination of excess fluid retention
by inappropriate levels of ADH and a loss of sodium due
to a normal response to increased body fluid provides a
description of SIADH. 
The causes of SIADH can be divided into four major
groups: tumors, drugs, pulmonary conditions, and CNS
disorders. In tumors, the cause of SIADH is usually ec-
topic secretion of ADH. Pharmacological agents have
been shown to stimulate secretion of vasopressin, potenti-
ate the antidiuretic effect of vasopressin, activate V2 renal
receptors, or work through a combination of mechanisms.
In pulmonary conditions, hypoxia and decreased venous
return have been thought to be the mechanism leading to
SIADH. The mechanism by which CNS disorders cause
SIADH is not well understood. Most authors hypothesize
that injury to the CNS disrupts or alters the osmoregula-
tion of ADH release by the neurohypophysis, stimulating
inappropriate release of ADH. The exact mechanism by
which this occurs is not well known; however, SIADH
seems to be an acute and self-limited disorder that lasts
only a few days or weeks.
SPINAL SURGERY AND SIADH
The SIADH has been reported after spinal surgery by
many authors.2,5,7 Elster7 reported a 5% incidence of post-
operative SIADH in a retrospective review of 161 patients
who underwent spinal surgery. Callewart, et al.,5 reported
a postoperative incidence of 6.9% SIADH in their pro-
spective study of 116 patients who underwent spinal
surgery. Lieh-Lai, et al.,12 reported a postoperative inci-
dence of 33% SIADH in a prospective cross-sectional
study of 30 pediatric patients. In their prospective study of
10 patients, Bell and associates2 reported a 100% inci-
dence of SIADH in patients who underwent spinal fusion.
Although these reported incidences range from 5 to
100%, it is important to recognize the risk of postopera-
tive SIADH in patients undergoing spinal surgery. Close
observation and early diagnosis are very important in the
appropriate treatment of patients with SIADH. 
Symptoms and Diagnosis
Symptoms of SIADH may vary, depending on its rate
of development from mild headache, muscle cramps, and
anorexia to nausea, vomiting, confusion, coma, convul-
sions, and death. The first sign of developing SIADH usu-
ally is a decrease in urine output with an associated in-
crease in urine specific gravity.12 Lieh-Lai, et al.,12 found
that the ADH level was elevated immediately and 6 hours
postoperatively, and that it returned to preoperative values
within 12 hours. They also found that serum osmolali-
ty decreases below normal within 6 hours after surgery.
These findings indicate that SIADH develops in patients
immediately postoperatively. Hence, a close observation
of decreases in urine output and the serum level of sodium
may help diagnose SIADH early. It should be noted that
the level of ADH may rise postoperatively as a physio-
logical response to hypovolemia or hypotension. Hence,
to diagnose SIADH, the specific constellation of signs that
Schwartz and colleagues19 originally described (Tables 1
and 2) should be used. These include serum hypoosmolal-
ity (✂ 275 mOsm/kg), inappropriate urinary concentra-
tion (urine osmolality ✄ 100 mOsm/kg), and elevated uri-
nary excretion of sodium in the absence of hypovolemia.
In addition, other medical causes of hyponatremia, such as
hypovolemia and renal, adrenal, or thyroid dysfunction,
should be excluded. Any medication that might cause hy-
ponatremia should also be excluded. 
Any decrease in urine output should prompt the clini-
cian to perform an additional workup. The serum level of
sodium should be measured. If the level is less than 130
mEq/L, serum and urine osmolality should be checked. If
these values are less than 275 mOsm/kg H2O and more
than 100 mOsm/kg H2O (Table 2), respectively, the pa-
tient’s fluid status should be accessed. Intravascular fluid
volume can be assessed either directly by measuring CVP
or indirectly by challenging the patient with a bolus of
fluid. If CVP is high or the urine osmolality does not
change in response to the fluid challenge, other causes of
SIADH should be ruled out. In the presence of normally
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TABLE 1
Clinical parameters used to diagnose SIADH
decreased plasma osmolality ( 275 mOsm/kg H2O)
inappropriate urinary concentration (✁100 mOsm/kg H2O)
clinical euvolemia/hypervolemia or absence of signs of hypovolemia or
hypervolemia
elevated urinary excretion of sodium w/ a normal salt & water intake
absence of other causes of increased ADH such as hypothyroidism,
hypoadrenalism, kidney problem, & diuretic use
TABLE 2
Clinical comparison of SIADH and the normal ADH response
Parameter SIADH Normal-Response ADH
plasma sodium low ( 130 mEq/L) low
plasma osmolality low ( 275 mOsm/kg H2O) normal–low
urine sodium high (✁20 mEq/L) low
urine osmolality high (✁100 mOsm/kg H2O) high
plasma uric acid low high
functioning kidneys, adrenals, and thyroid gland, the diag-
nosis of SIADH can be made.
Treatment of SIADH
It is very important to distinguish between SIADH and
appropriate-response ADH because the management of
the two conditions is markedly different. In the face of
SIADH, volume expansion should be avoided. In patients
with a known cause of SIADH, the disorder can be cured
by eliminating the cause, for example, the tumor, drug, or
disease responsible for the syndrome. In CNS and spine
disorders, SIADH can be an acute self-limited disorder
that remits spontaneously within 2 or 3 weeks. 
In patients whose SIADH is related to a CNS or spinal
disorder, depending on the severity of the hyponatremia, it
is important to correct the salt and water imbalance while
waiting for the inappropriate release of ADH to cease. In
mild hyponatremia with minimal symptoms, reducing to-
tal intake of free water and increasing the oral intake of
salt often is sufficient to reduce the amount of body water
and raise the serum level of sodium. In patients with sig-
nificant hyponatremia and CNS manifestations, it is im-
portant to decide how fast and to what level the plasma
osmolality should be increased. Correcting severe hypo-
natremia too rapidly could be devastating because it might
cause CPEM, a demyelinating disease that causes severe
morbidity and mortality, including quadriparesis, mutism,
pseudobulbar palsy, seizures, behavioral disturbances, and
movement disorders.1,21,24
There is great debate over how fast and how much the
serum level of sodium should be corrected. Early studies
found less risk of CPEM with increases in serum sodium
less than 25 mEq/L over the first 24 to 48 hours of treat-
ment.20,25 Authors of later studies, however, have suggest-
ed that the risk of CPEM is much higher if the serum level
of sodium is corrected faster than 12 mEq/L in 24 hours or
18 mEq/L in 48 hours.22 In addition, the duration of hypo-
natremia is important in its treatment. Perioperative hypo-
natremia, often an acute process (✂ 48 hours), is associat-
ed with a higher risk of developing complications from
hyponatremia and is rarely associated with demyelinating
complication with rapid correction. Hence, if hyponatre-
mia has developed acutely after surgery, it should be cor-
rected rapidly. If hyponatremia is a chronic process, how-
ever, it should be corrected in a controlled and limited
fashion. Some authors have suggested correcting the se-
rum level of sodium at a rate of 1 to 2 mEq/L per hour,
while keeping the total magnitude of correction to less
than 25 mEq/L over the first 48 hours.20,25 Nevertheless,
we use more conservative parameters: a maximal correc-
tion rate of 0.5 mEq/L per hour and overall magnitudes of
correction less than 12 mEq/L in the first 24 hours and 18
mEq/L in the first 48 hours.22
When treating hyponatremia with an intravenous ad-
ministration of 3% saline solution, the serum level of sodi-
um and urine output should be monitored closely to en-
sure prompt recognition and discontinuation of treatment
if SIADH acutely remits. Lithium carbonate and deme-
clocycline have been shown to increase the excretion of
free water by blocking the effect of ADH at the level of
the collecting duct. Both of these drugs carry the risk of
severe complications, however, and should be used only
in patients who cannot comply with water restriction and
a high dietary salt intake or in whom this therapy fails.
Although ADH antagonists are still in the experimental
stages, they offer the promise of treating severe hypona-
tremia quickly.15,24
CONCLUSIONS
The SIADH is the principal cause of postoperative hy-
ponatremia in patients who have undergone spinal sur-
gery. Early recognition of signs and symptoms is very
important for a prompt diagnosis and treatment of postop-
erative SIADH. Special attention should be given to the
aggressiveness of and length of treatment for the correc-
tion of hyponatremia to avoid the serious possible com-
plication of overtreatment of hyponatremia.
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